Current histopathologic classification schemes for gastric adenocarcinoma have limited clinical utility and are difficult to apply due to tumor heterogeneity. Elucidation of molecular subtypes of gastric cancer may contribute to our understanding of gastric cancer biology and to the development of new molecular markers that may lead to improved diagnosis, therapy, or prognosis. We previously demonstrated that Epstein-Barr virus (EBV)-infected gastric cancers have a distinct human gene expression profile compared with uninfected cancers. We now examine the histopathologic features characterizing infected (n = 14) and uninfected (n = 89) cancers; the latter of which are now further divided into 2 major molecular subtypes based on expression patterns of 93 RNAs. One uninfected gastric cancer subtype was distinguished by upregulation of 3 genes with neuroendocrine (NE) function (CHGA, GAST, and REG4 encoding chromogranin, gastrin, and the secreted peptide REG4 involved in epithelial cell regeneration), implicating hormonal factors in the pathogenesis of a major class of gastric adenocarcinomas. Evidence of NE differentiation (molecular, immunohistochemical, or morphologic) was mutually exclusive of EBV infection. EBV-infected tumors tended to have solidtype morphology with lymphoid stroma. This study reveals novel molecular subtypes of gastric cancer and their associated morphologies that demonstrate divergent NE features.
Gastric adenocarcinomas also have diverse pathogenesis, with Helicobacter pylori and Epstein-Barr virus (EBV) both designated as associated class 1 oncogenic pathogens by the World Health Organization. Approximately 10% of gastric adenocarcinomas harbor EBV infection in the neoplastic epithelial cells. 18 The prevalence of EBV infection is significantly higher (>80%) in the specific histologic type variably termed "gastric carcinoma with lymphoid stroma" or "lymphoepithelioma-like carcinoma." [19] [20] [21] [22] [23] [24] This tumor type is characterized by undifferentiated epithelial cells and an abundant lymphocytic infiltrate distributed uniformly throughout the tumor, similar to EBV-associated nasopharyngeal carcinoma. Gastric carcinoma with lymphoid stroma has a survival advantage over other histologic types, 22, 23 however, the literature varies on whether EBV positivity alone or histopathologic appearance trumps in assigning prognosis. 23, [25] [26] [27] [28] When EBV-associated gastric cancers are classified according to their histologic patterns, some studies report predominance of Lauren intestinal type, 26 tubular type, 26, 29, 30 Lauren diffuse type, 20, 23, 27 and medullary/solid type. 30, 31 This variability may illustrate the interpretative bias inherent in applying morphologic criteria.
High-grade neuroendocrine (NE) carcinoma is another heterogeneous group of gastric malignancies classified and staged separately from gastric adenocarcinomas by the World Health Organization. 32 It is frequently underrecognized because of the broad morphologic spectrum (from classic small cell carcinoma to poorly defined large cell carcinoma) and overlap with poorly differentiated adenocarcinoma. [33] [34] [35] [36] Admixed adenocarcinoma components can be found in tumors of any of the NE carcinoma subtypes, presenting a challenge in terms of the overall tumor classification. In fact, evidence of focal NE differentiation has been found in over 50% of tumors otherwise classified as adenocarcinoma. [37] [38] [39] [40] It is particularly common in signet-ring cell carcinomas, leading some to propose that signet-ring cells derive from a pluripotent NE stem cell. [41] [42] [43] [44] Molecular and infectious correlates of NE differentiation have not been systematically investigated.
Molecular profiling holds promise for adding value in categorizing disease in a manner that is clinically meaningful. We previously demonstrated that EBV-infected gastric cancers have a distinct human gene expression profile compared with uninfected gastric cancers. 45 In the current study, we examine RNA expression patterns to further divide uninfected cancers into 2 principal molecular subtypes, and we evaluate associations with tumor histology and NE gene expression. This study is the first, to our knowledge, to investigate the relationship between EBV infection and NE differentiation in gastric cancer.
MATERIALS AND METHODS

Tissue and Molecular Profiling
Consecutive gastric adenocarcinoma cases on which sufficient residual formalin-fixed paraffin-embedded tissue was available were assembled from pathology archives of 3 hospitals in disparate parts of the world, 30 from the University of North Carolina Hospitals in Chapel Hill, USA, 133 from Western Regional Hospital in Santa de Rosa, Honduras, and 24 from Wakayama Medical University, Wakayama, Japan. RNA profile data on this case cohort were previously published, and histopathology correlates are the subject of the current study. Studies were performed with approval of the University of North Carolina Biomedical Institutional Review board. 45 Paraffin-embedded tissue sections were stained with hematoxylin and eosin (H&E) and reviewed to identify tumor for subsequent macrodissection from unstained adjacent sections. Nucleic acid was extracted and RNA expression analysis was performed on the nCounter system (Nanostring) as previously described. 45 A custom panel of 96 RNAs (Gastrogenus v1 panel) was measured which includes 73 human mRNAs of which 4 were housekeeper transcripts, 20 viral RNAs (7 latent, and 9 lytic EBV mRNA transcripts, EBER1 and EBER2 noncoding RNAs, and 2 cytomegalovirus mRNAs), and 3 spiked ERCC RNA controls. The human RNAs were selected based on their proposed roles in gastric cancer pathogenesis, inflammatory response, and/or gastric cancer therapeutic targeting and monitoring. The viral RNAs were selected to detect EBV and to measure expression of latent and lytic viral transcripts. After excluding samples with insufficient RNA or insufficient histopathologic material for morphologic assessment, a total 103 gastric carcinomas were included in the study. Of note, biopsies tended to yield better-quality RNA than did resection specimens, possibly because biopsies tend to be immersed in formalin preservative much more quickly than are resected tumors.
Histologic Analysis
All tumors were classified by both the Lauren system 1 and by the Carneiro system. 7, 46 In the Carneiro classification of gastric cancer, mixed carcinomas consisting of both glands and infiltrating single cells, as well as solid carcinomas, are classified separately from purely gland-forming tumors and isolated-cell tumors. The latter 2 tumor categories correspond to Lauren intestinal and diffuse types, respectively. Solid carcinomas are composed of tumor cell sheets with little or no gland formation and these tend to form expansile rather than infiltrative masses. 11 Solid tumors typically lack a significant stromal component and correspond to the medullary type distinguished by Kubo. 4 Others have used yet another term, "cohesive carcinoma," 8 when individual cells or small groups of tumor cells in solid/medullary/ cohesive formations lack investment by stroma in contrast to isolated-cell type. Thus, in the Carneiro classification scheme histologic group 1 is isolated-cell, group 2 is gland-forming, group 3 has mixed gland-forming and single cell components, and group 4 is solid. A number of cases remained unclassified by this 4-group system due to the scant nature and quality of biopsy material. Tumors with NE morphology by H&E were also placed in the unclassified category as well as being considered separately for statistical analysis (see below).
Morphologic features suggesting NE differentiation on H&E were evaluated as previously described for NE carcinomas, namely, nested/organoid, trabecular, and rosette-forming architecture, relative cellular monotony, eosinophilic cytoplasm, indistinct cellular borders, and evenly dispersed chromatin. 3, 33, 34, 47 Formal mitotic counts were not performed due to a preponderance of small biopsy specimens with limited numbers of highpower fields; however, mitoses were noted in the majority of tumors with NE features. Tumors were characterized as signet-ring cell carcinomas if >50% of malignant cells were signet-ring cells. The degree of chronic inflammatory cell infiltrate within the tumor was graded semiquantitatively as mild, moderate, or severe. Stromal fibrosis (desmoplasia) was also graded semiquantitatively as mild, moderate, or severe, reflecting a relative proportion of stromal spindle cells to tumor cells.
Histochemistry
EBV-encoded RNA (EBER) in situ hybridization was performed on paraffin sections (Leica BOND Max system with EBER ASR probe and oligo dT control probe detected using the Bond Polymer AP Red Detection reagents; Leica Microsystems Inc., Buffalo Grove, IL) 48, 49 to determine if EBV was localized to malignant epithelial cells. EBV localization to scattered lymphocytes was seen in some EBV-positive and EBV-negative tumor tissues as previously reported. 50 Representative histologic tumor types from all 3 molecular groups were selected for immunohistochemistry using antibodies to chromogranin A (Leica, 1:200) and synaptophysin (Leica, 1:200). Avidin-biotin complex peroxidase techniques were used for signal detection on 4-mm sections of formalin-fixed, paraffin-embedded tissues. Antigen retrieval in hot citrate buffer at pH 6.0 was applied before immunostaining.
Statistics
Unsupervised hierarchical clustering revealed the EBV-infected molecular subtype for which EBV localization to malignant cells was proven by EBER in situ hybridization. Two additional uninfected molecular classes of gastric cancer were identified on heat maps created using Cluster 3.0 and JavaTreeView software algorithms applied to log2 transformed gene expression data collected on the nCounter system. Genes differentially expressed among the 3 molecular types of cancer were identified using nonparametric Mann-Whitney tests, and P-values were adjusted using Bonferroni correction to account for multiple comparisons. A Bonferroni-adjusted P < 0.05 connoted significant differential expression. Box plots show the median and middle 2 quartiles surrounded by whiskers depicting outliers which are far above or below the interquartile range (IQR) by >Q3+1.5 Â IQR or <Q1 À 1.5 Â IQR, respectively. Associations between discrete histologic parameters and the 3 molecular types of cancer were evaluated by Fisher exact test or Pearson's w 2 test. Statistical analysis was repeated after limiting the cohort to the 2 uninfected gastric cancer molecular types.
RESULTS
RNA Expression Profiling Reveals 3 Molecular Subtypes of Gastric Adenocarcinoma
The 96-RNA probe test panel that included 73 human mRNAs, 20 viral RNAs, and 3 controls (Gastrogenus v1 panel) was applied to 103 macrodissected gastric adenocarcinoma tissues. After data normalization, unsupervised clustering identified 3 major molecular subtypes, 1 with high expression of EBV RNAs, and 2 lacking substantial levels of EBV RNA. The cancers overexpressing EBV RNAs were called the EBV-positive molecular type (n = 14), and all 14 were proven to have EBV localized to malignant cells by EBER in situ hybridization which is the gold standard assay for defining a tumor as infected. 45, 50 Three RNAs involved in the differentiation and signaling of NE cells of the gut, CHGA (chromogranin), GAST (gastrin), and REG4 (regenerating islet-derived family, member 4), were significantly overexpressed in 1 noninfected molecular subtype. Henceforth, the 2 uninfected molecular subtypes are referred to as NE-high (n = 34) and NE-low (n = 55) ( Fig. S1 , Supplemental Digital Content 1, http://links.lww.com/ AIMM/A57).
NE RNAs Distinguish the 3 Molecular Subtypes
Of the 73 human RNAs that were measured, 43 were significantly differentially expressed among the 3 molecular groups. The 9 human genes more highly expressed in EBV-positive compared with EBV-negative cancers are involved primarily in the antiviral inflammatory/immune response as previously described. 45 The NE markers CHGA, GAST, and REG4 were expressed at a lower level in the EBV-positive compared with the NE-high molecular type. Levels of these NE markers in the NE-low molecular type were intermediate between those in the EBV-positive and NE-high groups, suggesting that the EBV-positive tumors had the least amount NE differentiation ( Fig. 1 ).
Statistical analysis comparing the NE-high and NElow molecular types revealed differential expression of 32 RNAs (Table 1) . Only 3 genes were upregulated in NEhigh compared with the NE-low molecular subtype, and these were the 3 NE markers. The remaining 29 RNAs were downregulated in the NE-high group, and these downregulated RNAs include adhesion factors and intracellular signaling molecules (ICAM1, FSCN1, SULF1, SPP1, INHBA), and collagen components COL1A1, COL1A2, and COL3A1. In addition, many inflammatory and immune response genes are downregulated in the NE-high compared with the NE-low molecular types, implicating stromal cells as a factor influencing clustering. The EBV genes EBER1, EBER2, and BLLF1 were relatively underexpressed in NE-high compared with the NElow molecular types, although the levels of these viral RNAs did not approach the elevated levels seen in the EBV-infected carcinomas. Rare EBV-infected stromal lymphocytes could be a source of these viral RNAs in uninfected cancer tissues.
Histologic Analysis
H&E-stained sections were analyzed to determine histologic classification, to examine stromal content for the extent of chronic inflammation and fibrosis, and to query for morphologic evidence of NE differentiation ( Table 2) . EBV-positive molecular type cancers were noted to have more chronic inflammation compared with NE-high or NE-low tumors and were much more likely to be designated as "gastric carcinoma with lymphoid stroma" (Fig. 2 ). EBV-positive cancers (7/14) received this designation versus 0/34 NE-high and 1/55 NE-low cancers. Tumors with more lymphocytic infiltrate generally showed less stromal desmoplasia, and no EBVpositive molecular type cancers were noted to have severe stromal fibrosis. EBV-positive molecular type cancers were comprised of sheets or large nests of tumor cells with absent or minimal desmoplastic stroma, characteristic of solid carcinoma of the stomach. Focal gland formation was present in some of the otherwise solid-appearing EBV-positive cancers but the focal glands were not associated with stromal infiltration. There was a statistically significant association between the 4 histologic Carneiro groups and the 3 molecular types (P < 0.05) (Table 2, Fig. 3 ). As described above, EBV-positive carcinomas were predominantly group 4 solid. The NE-high molecular type had a greater proportion of group 1 isolated-cell histology tumors (14/ 34 cases, 41%) compared with the EBV-positive (0/14) and NE-low type tumors (10/55, 18%), and a greater proportion of signet-ring cell carcinomas-11/34 (32%) NE-high tumors were signet-ring cell carcinomas compared with 0/14 EBV-positive tumors and 4/55 (7%) NE-low tumors. Classification of tumors into Lauren categories did not have a statistically significant association with molecular subtypes.
Although all gastric cancers in this study were diagnosed as adenocarcinoma rather than NE carcinoma, a number of cases were found to have architectural and cytologic NE features on H&E stain, such as nested or rosette-forming architecture, cellular monotony, and evenly dispersed chromatin (Fig. 4 ). In addition, some cases had high-grade NE features with increased nuclear/ cytoplasmic ratios, hyperchromatic nuclei, and conspicuous mitotic activity. Four biopsy cases additionally showed extensive nuclear molding, single cell apoptosis, and crush artifact, fulfilling the criteria for classic small cell carcinoma (Fig. 4E ). Two of these small cell carcinoma cases were NE-high and 2 were NE-low molecular subtype. However, in other cases determination of highgrade versus low-grade NE tumor features could not be made due to the limited size of biopsy material. All tumors with any morphologic NE features were separated out for purposes of statistical analysis. While none of the 14 EBV-positive cancers had NE features by H&E, such features were found in 4/34 NE-high and 10/55 NE-low molecular type tumors, but this relationship did not reach statistical significance.
Genes Associated With Histologic Subtypes
RNAs differentially expressed among the 4 Carneiro histologic groups included primarily viral RNAs and those human RNAs involved in the inflammatory/immune response. These RNAs were upregulated in group 4 solid carcinomas which includes the majority of EBV-positive molecular type cancers. Four human RNAs not generally considered part of the inflammatory repertoire that were significantly differentially expressed among the histologic groups are CHGA (P = 0.007), PLUNC (P = 0.008), CYP2W1 (P = 0.014), and PPARG (P = 0.035). CHGA was expressed at a higher level in group 1 isolated-cell tumors and group 3 mixed tumors, whereas PLUNC was expressed at higher level in group 4 solid tumors (Fig. 5) . No RNAs were differentially expressed in association with morphologic evidence of NE differentiation. Similarly, no RNAs were significantly associated with the Lauren classification or with signet-ring cell morphology.
Chromogranin RNA Level and Protein Immunohistochemistry
Given the significant association of the molecular groups with the expression of NE RNAs, we assessed NE differentiation by immunohistochemistry for chromogranin and synaptophysin in representative tumors from the 3 molecular types (Table S1, Supplemental Digital Content 2, http://links.lww.com/AIMM/A58). Immunohistochemistry could be performed only on a small fraction of study samples in part because tissue from many biopsy cases had been exhausted for RNA extraction. Immunohistochemistry was attempted in 16 cases with 14 yielding sufficient tissue for analysis, 5 NE-high cases, 7 NE-low cases, and 2 EBV-positive cases. In the NE-high subtype, chromogranin staining was positive in 4/5 cases (1 NE/small cell carcinoma, 2 isolated-cell carcinomas, and 1 mixed carcinoma). One NE-high case with NE morphology was negative for chromogranin but positive for synaptophysin. In the NE-low subtype, chromogranin staining was positive in 1/7 cases (1 isolatedcell carcinoma), whereas negative in 2 solid carcinomas and 4 NE carcinomas, including 2 small cell carcinomas. Three of the 4 chromogranin-negative NE carcinomas were synaptophysin positive. Neither of the 2 EBV-positive cases had positive chromogranin or synaptophysin staining. No statistically significant correlation between chromogranin RNA level and protein expression could be established (P = 0.06).
NE Differentiation is Observed Only in the Non-EBV-infected Molecular Type Cancers
Although only a small number of samples were investigated by immunohistochemistry, positive antibody staining for NE markers was observed only in non-EBV-infected molecular type cancers. EBV-positive molecular type cancer with solid morphology lacks chromogranin or synaptophysin-expressing malignant cells (Figs. 6A-C) . In contrast, scattered single tumor cells positive for chromogranin or synaptophysin were seen in NE-high molecular type cancers that were group 1 isolated-cell histology (Figs. 6D-F) . NEhigh tumors with signet-ring cells also showed scattered chromogranin or synaptophysin-positive cells (Figs. 6G-I). NE-low molecular type tumors with isolated-cell histology similarly had NE expressing cells. In 1 such tumor, 2 differently staining NE elements corresponded to 2 distinct H&E appearances: 1 with intracellular mucin and signet-ring cell appearance and the other with enlarged vesicular nuclei, prominent nucleoli, and eosinophilic cytoplasm (Figs. 6J-O) . In retrospect, these atypical nuclear features might be con-sistent with large cell NE carcinoma (see the Discussion section).
Agreement Between NE Differentiation by Morphology and Immunohistochemistry is Imperfect
Several tumors with features of NE differentiation assessed by H&E showed at least focal synaptophysin and/or chromogranin staining (Fig. 4) . These tumors often had multiple morphologies within the same tumor evident even in small biopsy specimens. For example, 1 synaptophysin-positive case showed areas of tumor forming NE rosettes and areas of solid nests (Figs. 4A-C). The nuclear features were high grade in both areas with hyperchromasia and nuclear molding. Several other cases had clearly distinct glandforming/tubular and nested NE components (Fig. 4D) . A small cell carcinoma that was chromogranin positive had scattered signet-ring cells (Figs. 4E, F) .
However, the initial morphologic assessment of NE features did not always correlate with positive immunohistochemistry for synaptophysin and chromogranin. At least 1 case considered to be a high-grade NE carcinoma by H&E did not show any synaptophysin or chromogranin reactivity (Figs. 7A, B ). This tumor had nested architecture and 2 cytologically distinct cell populations, 1 with finely clumped, salt-and-pepper chromatin and more abundant cytoplasm, and the other with nuclear hyperchromasia, increased nuclear/cytoplasmic ratio, and nuclear molding. Conversely, an NE-low molecular subtype tumor that was initially not noted to have NE features on H&E showed synaptophysin positivity. This tumor was classified as a group 1 isolated-cell carcinoma with pleomorphic signet-ring cells although with unusually little stromal fibrosis (Fig. 7C) . On reexamination there were minor areas of trabecular/ nested growth composed of eosinophilic nonsignet-ring cells with hyperchromatic nuclei, indistinct cell borders, and nuclear molding-features of high-grade NE carcinoma (Fig. 7D ). Lack of fibrosis and packed appearance of both signet-ring cells and eosinophilic cells can also favor classification as solid carcinoma. In our experience, however, solid carcinomas without NE features have a different appearance with round cell shapes, well-defined cellular borders, absent nuclear molding, and sheet-like rather than nested growth. Figure 7E shows 1 such tumor of the NE-low molecular subtype classified as solid (group 4). This tumor showed no NE differentiation by chromogranin or synaptophysin immunohistochemistry. 
DISCUSSION
In this study, RNA expression arrays were applied to profile and cluster gastric cancer tissues, which yielded 3 molecular types of cancer. These 3 molecular types were distinguished from one another based primarily on EBV status and by the degree of expression of NE RNAs. Furthermore, these molecular types correlated in part with histologic features and with histochemical test results for EBV infection and for NE differentiation. The EBVpositive molecular type cancers uniformly expressed EBER in the malignant cells by in situ hybridization. We previously showed that these infected cancers expressed multiple EBV genes as well as a subset of human genes involved in inflammatory response (TNFSF9, TRAF1, CXCL11, IFITM1, and FCRL3). 45 Overexpression of the B-cell markers MS4A1 (CD20) and FCER2 (CD23), and the suppressor T-cell marker CD8 are consistent with the chronic inflammatory cell infiltrate in these tumors and their frequent morphologic diagnosis as "gastric carcinoma with lymphoid stroma." The correlation between the abundant tumor-infiltrating lymphocytes and the molecular evidence of inflammatory response lends validity to the molecular profiling system used in this study.
EBV-positive cancers in this study tended to have solid morphology with minimal fibrosis, features noted by others as well. 19, 51 This morphologic type is distinguished by the Carneiro gastric cancer classification but not by the Lauren classification. EBV-positive cancers also had more chronic inflammation in keeping with lymphoid stroma rather than fibrotic stroma. None of the EBV-positive cancers were signet-ring cell type, although more cases must be studies to evaluate whether this findings is significant.
A significant finding in the EBV-positive cancers was the lack of NE differentiation as evaluated by H&E histology, immunohistochemistry, and RNA expression. Molecular profiling divided the noninfected cancers in this study into 2 groups that differed from each other in the expression of 3 RNAs known to be associated with NE cell differentiation in the gut, CGHA, GAST, and REG4. [52] [53] [54] However, we did not find a significant correlation between RNA expression and NE appearance on H&E. There was also no correlation between chromogranin protein positivity assessed by immunohistochemistry and chromogranin RNA expression. Discordance between chromogranin protein and RNA expression has been described in pulmonary small cell carcinomas. [55] [56] [57] Immunoreactivity for chromogranin is associated with the presence of neurosecretory granules in tumor cells, and many high-grade NE carcinomas have absent or aberrant production of such granules. Among primary pulmonary small cell carcinomas, immunopositivity for chromogranin is generally only around 80% 58 and has been reported as low as 23%. 59 Absent or focal chromogranin staining in gastric NE carcinomas is also a known phenomenon with reported chromogranin positivity of 40%. 47 The lack of correlation between NE RNA expression level and NE morphology in this study may be due to (1) the small number of tumors with NE morphology; (2) poor reproducibility of NE carcinoma morphologic diagnosis; (3) expression of NE RNAs in nonmalignant cells; or (4) biopsy sampling may not be representative of the entire tumor. We conclude that while NE RNAs seem to be major drivers of molecular subtype in this study, it was not possible to use H&E nor standard immunostain evidence of NE differentiation to predict molecular subtype.
In 2-way analysis, NE-high and NE-low molecular types differed not only in NE-related transcripts but also in the expression levels of several other genes involved in intercellular signaling and adhesion as well as inflammation and metabolism. It should be noted that only 73 human RNAs were profiled, and thus there is limited ability to examine pertinent biochemical pathways in these tumors.
Recent progress towards targeted therapy for gastric cancer is refining the way that cancer is classified. Already implemented in routine patient care are tests for ERBB2(HER2) protein expression or gene amplification as a means to predict therapeutic efficacy of trastuzumab. In our study, ERBB2 RNA was expressed in some tumors but it was not differentially expressed among the 3 molecular types that we delineated. 45 Multiple investigators are pursuing strategies for virus-targeted therapy in the subset of cancers that are EBV infected. [60] [61] [62] [63] Efforts focused on molecular and histochemical assays will add value to the histopathologic classification of gastric cancer given the intertumoral and intratumoral heterogeneity that confounds histologic evaluation.
Our findings highlight the difficulty in applying NE carcinoma designation. Some tumors assessed as having NE morphology by H&E were negative for chromogranin or synaptophysin immunohistochemistry. Conversely, some tumors not suspected to have NE differentiation showed NE marker positivity by immunohistochemistry. Multiple studies have found that NE differentiation is underrecognized by morphology alone, and ancillary methods often reveal evidence of it in various tumor types. 39, 47, 54, 64 Large cell NE carcinoma is especially difficult to distinguish from poorly differentiated adenocarcinoma because of overlapping cytologic features and growth patterns, and even accumulation of intracellular mucin is permissible in large cell NE carcinoma. [33] [34] [35] In our study we observed intertumoral and intratumoral heterogeneity in tumors with NE morphologic features as well.
One important question is: does NE differentiation in gastric cancer have clinical implications? It seems clear that tumors fulfilling the diagnostic criteria for small cell carcinoma are a distinct group of biologically aggressive malignancies. 65 Prognostication becomes more difficult when the high-grade NE component constitutes only part of the tumor. One study set a threshold for tumor designation as large cell NE carcinoma if the NE component was >50% of the tumor by chromogranin immunostain. 33 In that study, adenocarcinomas with 20% to 50% chromogranin-positive large cell NE component showed reduced survival compared with adenocarcinoma with no NE component. There have been conflicting reports of a worse 37, 39 or better 41, 66 prognosis associated with any focal NE differentiation by immunohistochemistry. Given the uncertainty of the morphologic criteria and the variability of protein immunohistochemistry, it seems logical to ask if an RNAbased molecular test may provide a more objective measure of NE differentiation. Further studies are necessary to test if an RNA threshold is clinically significant, and to compare the performance of RNA-based tests to protein immunohistochemistry. It is likely that tumors with a clinically significant level of NE differentiation would be defined not by a single RNA but by a panel of several RNA markers such as the ones used in this study. An important limitation of this study is the lack of outcome data to determine if the 3 molecular subtypes correspond to gastric cancer subsets with clinically significant differences in disease progression or response to therapy.
In conclusion, our study shows molecular evidence of NE differentiation in over a third of gastric adenocarcinomas. However, EBV-infected tumors completely lack NE differentiation either in their molecular profile or by morphology. EBV-infected tumors are predominantly solid morphologic type which is distinguished by the Carneiro histologic classification but not the Lauren classification. Our study also confirms that molecular profiling has promise as a robust tool, applicable in small fixed biopsies, to add value in classifying gastric cancer.
